Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117166) titled 'A longitudinal study on the symptoms of liver cancer patients during different periods of targeted and immune therapy based on network analysis, and their predictive role on quality of life' on Jan. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Hospital of Jiaxing
Condition:
liver cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-23
Target Sample Size: Observation group:228;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=285828
Disclaimer: Curated by HT Syndication....